CME Group Inc. $CME Shares Sold by EFG Asset Management Americas Corp.

EFG Asset Management Americas Corp. trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 7.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 34,796 shares of the financial services provider’s stock after selling 2,802 shares during the quarter. CME Group accounts for about 1.6% of EFG Asset Management Americas Corp.’s investment portfolio, making the stock its 14th biggest position. EFG Asset Management Americas Corp.’s holdings in CME Group were worth $9,401,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. EagleClaw Capital Managment LLC boosted its holdings in CME Group by 0.8% in the third quarter. EagleClaw Capital Managment LLC now owns 39,174 shares of the financial services provider’s stock valued at $10,584,000 after purchasing an additional 294 shares during the last quarter. Emmett Investment Management LP increased its holdings in CME Group by 12.9% during the 3rd quarter. Emmett Investment Management LP now owns 39,405 shares of the financial services provider’s stock worth $10,475,000 after purchasing an additional 4,495 shares during the last quarter. Cannell & Spears LLC raised its position in shares of CME Group by 27.3% in the 3rd quarter. Cannell & Spears LLC now owns 2,785 shares of the financial services provider’s stock valued at $753,000 after purchasing an additional 598 shares in the last quarter. Capitolis Liquid Global Markets LLC acquired a new position in shares of CME Group in the 3rd quarter valued at approximately $5,116,000. Finally, Cinctive Capital Management LP purchased a new position in shares of CME Group during the 3rd quarter valued at approximately $1,977,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on CME shares. The Goldman Sachs Group raised their price target on shares of CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a research report on Monday, February 9th. Royal Bank Of Canada increased their price objective on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. Raymond James Financial decreased their price objective on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Morgan Stanley boosted their target price on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, UBS Group restated a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $303.53.

Insider Buying and Selling at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the transaction, the director directly owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard acquired 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the transaction, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders have sold 5,248 shares of company stock valued at $1,616,700. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $311.40 on Friday. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $112.29 billion, a price-to-earnings ratio of 27.90, a price-to-earnings-growth ratio of 3.36 and a beta of 0.24. CME Group Inc. has a twelve month low of $248.53 and a twelve month high of $329.16. The business has a 50 day simple moving average of $295.80 and a 200-day simple moving average of $278.99.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the business posted $2.52 earnings per share. As a group, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Tuesday, March 10th. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is 46.59%.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Rothschild & Co Redburn raised its price target on CME to $347 (maintaining a “neutral” rating), implying roughly double-digit upside from recent levels and offering fresh analyst support for the shares. Rothschild Co Redburn adjusts price target on CME to 347 from 333, maintains neutral rating
• Neutral Sentiment: CME’s CEO Terry Duffy publicly warned that U.S. government intervention in oil futures markets would be highly damaging; exchanges including CME have voiced opposition to potential Treasury action. This raises policy/regulatory risk for energy derivatives but also underscores the exchange’s central role in market integrity — a factor that can support trading volumes in energy products if volatility rises. US intervention in oil futures would be ‘biblical disaster’, CME warns CME Group CEO warns against US intervention in oil futures markets US intervention in oil futures market could be disastrous: CME Group
• Neutral Sentiment: Short-interest reporting in recent feeds shows zero or nonsensical values and appears to be a data anomaly rather than a real bearish signal; treat those short-interest items with caution. (Market impact minimal until corrected.)
• Negative Sentiment: Insider selling: Ken Vroman (Chief Transformation Officer) sold about 5,160 shares (~$1.59M) and SEC filings show multiple recent insider sales across senior staff. While insider sales can be routine, the cadence and size may raise governance/owner-sentiment questions for some investors. CME Group’s Vroman sells $1.59 million in stock Insider Sale: Chief Transformation Officer of $CME Sells 5,160 Shares

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.